Shopping Cart
- Remove All
- Your shopping cart is currently empty
SR-1277 is a highly potent, selective, and ATP competitive inhibitor of CK1δ/ε, with IC50 values of 49 nM and 260 nM, respectively. Additionally, SR-1277 exhibits inhibitory effects on FLT3, CDK4/cyclin D1, CDK6/cyclin D3, and CDK9/cyclin K, with IC50 values of 305 nM, 1340 nM, 311 nM, and 109 nM, respectively. Taken together, SR-1277 represents a valuable tool for cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | 6-8 weeks |
Description | SR-1277 is a highly potent, selective, and ATP competitive inhibitor of CK1δ/ε, with IC50 values of 49 nM and 260 nM, respectively. Additionally, SR-1277 exhibits inhibitory effects on FLT3, CDK4/cyclin D1, CDK6/cyclin D3, and CDK9/cyclin K, with IC50 values of 305 nM, 1340 nM, 311 nM, and 109 nM, respectively. Taken together, SR-1277 represents a valuable tool for cancer research. |
Targets&IC50 | CKIδ:49 nM (IC50), CKIϵ:260 nM (IC50) |
In vitro | SR-1277 demonstrates antiproliferative effects in A375 cells with an EC50 of 22 nM[1]. |
In vivo | SR-1277, administered intravenously at a dose of 1 mg/kg, demonstrates a peak concentration (C max) of 1.2 μM, a clearance rate (Cl) of 2.8 ml/min/kg, an area under the curve (AUC) of 1.26 μM·h, a half-life (T 1/2) of 1.42 hours, and a brain penetration rate of 24% in mice[1]. |
Molecular Weight | 477.5 |
Formula | C21H19N9O3S |
Cas No. | 1446715-47-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.